2019-09-13
2019-09-13
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
2019-09-14
2019-09-14
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
2019-09-15
2019-09-15
Plenary Hall
Ballroom A
Ballroom B
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
Plenary Hall
Ballroom A
Ballroom B
07:30
- 08:30
Morning Session 1: MSC therapy; Rationalism vs. Empiricism; How much must we know to test therapies in patients; a Live Debate

Allan B. Dietz, PhD (Chair)
Mayo Clinic, USA

Jacques Galipeau, MD
University of Wisconsin - Madison, USA

William Faubion, MD
Mayo Clinic, USA
07:30
- 08:30
Q&O Track 1: Media Fills

Rosemarie Bell,B.App.Sc Micro/Biochem MASM (Chair)
QIMR Berghofer Medical Research Institute/Q-Gen Cell Therapeutics, Australia

Adrian Gee, PhD
Baylor College of Medicine, USA
Aisha Khan, MS, MBA
University of Miami, USA
08:45
- 10:15
Plenary 1: Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs

Allan B. Dietz, PhD (Chair)
Mayo Clinic, USA

Gil Van Bokkelen, PhD
Athersys, USA

Etienne Sokal, MD, PhD
Promethera, Belgium
10:45
- 12:15
Workshop 1: ISCT-NAVRMA Joint Session – Veterinary Medicine in Developing Cell-Based Therapies and Bioengineering Approach for Human Clinical Use

Daniel Weiss, MD, PhD (Chair)
University of Vermont, USA

Tracy Webb, DVM, PhD (Chair)
Colorado State University, USA

Andrew Hoffman, DVM, DVSc, DACVIM
University of Pennsylvania School of Veterinary Medicine, USA

Kyla Ortved, DVM, PhD
University of Pennsylvania School of Veterinary Medicine, USA

Aimee Colbath, VMD, PhD, DACVS-LA
Michigan State University College of Veterinary Medicine, USA

Dori Borjesson, BA, DVM, MPVM, PhD
UC Davis School of Veterinary Medicine, USA
10:45
- 12:15
Q&O Track 2: Managing the Mushrooming Growth in Cell and Gene

Lynn O’Donnell, PhD (Chair)
Ohio State University, James Cancer Hospital Columbus, USA
Eric Gilles
Mayo Clinic IMPACT, USA
Kathryn Melsop
Stanford Laboratory for Cell & Gene Medicine, USA

Rosemarie Bell, B.App.Sc Micro/Biochem MASM,
QIMR Berghofer Medical Research Institute/ Q-Gen Cell Therapeutics, Australia

Jacques Galipeau, MD
University of Wisconsin - Madison, USA
10:45
- 12:15
Oral Abstracts Session 1

Patrick Hanley, PhD (Chair)
Children’s National Health System, USA
12:30
- 13:30
Fill/ Finish Challenges and Opportunities for Automation (Corporate Tutorial Hosted by Fresenius-Kabi)
13:45
- 15:15
Plenary 2: iPSC and Pluripotent Stem Cells – True Replacement Cell Therapies

Robert Deans, PhD (Chair)
BlueRock Therapeutics, USA

Dan Kaufman, MD, PhD
University of California San Diego, USA

Stephanie Protze, PhD
University of Toronto, Canada

Robert Deans, PhD
15:30
- 17:00
Workshop 3: Gene Replacement Therapy Using Adult Stem Cells

Mitchell Cairo, MD (Chair)
New York Medical College, USA

Mitchell Cairo, MD
New York Medical College, USA

Jeffrey Medin, PhD
Medical College of Wisconsin, USA

Paul Orchard, MD
University of Minnesota, USA
15:30
- 17:00
Q&O Track 3: Stability
Karl Stasko, MPH (Chair)
Dana-Farber Cancer Institute, Cell Manipulation Core Facility, USA
Karl Stasko, MPH
Dana-Farber Cancer Institute, Cell Manipulation Core Facility, USA

Jackie Damen, PhD
Senior Scientific Advisor, Hematopoiesis, Canada

Rosemarie Bell, B.App.Sc Micro/Biochem MASM,
QIMR Berghofer Medical Research Institute/ Q-Gen Cell Therapeutics, Australia
15:30
- 17:00
Workshop 2: ISCT Presidential Task Force – Regulatory Aspects of Unproven Cell and Gene Therapies in North America

Laertis Ikonomou, PhD (Chair)
Boston University, USA

Peter Marks, MD, PhD
Center for Biologics Evaluation and Research, FDA, USA

Lynne Boxer, DVM
Center for Veterinary Medicine, FDA, USA

Ajay Kuriyan, MD, MS
Department of Ophthalmology, University of Rochester Medical Center, USA

Kristin Matthews, PhD
Rice University's Baker Institute for Public Policy, USA
17:00
- 18:00
Breaking Bottlenecks – The Training, Development, and Staffing Challenge (Corporate Symposium Hosted By ISCT ESP Committee & CellCAN)
Emily Hopewell, PhD
ISCT ESP Committee Member, ISCT Global Treasurer, Indiana University School of Medicine, USA
Craig Hasilo, Msc, PhD(C)
CellCAN, Canada
07:30
- 08:30
Morning Session 2 – Meet the Experts: Cellular Therapy Quality and Operations

Lizette Caballero, BS, MLS(ASCP)CM (Chair)
UCSF Blood and Marrow Transplant Lab, USA

Paul Eldridge, PhD
UNC Lineberger Comprehensive Cancer Center, USA

Olive Sturtevant, MHP, MT(ASCP)SBB
Dana-Farber CMCF, USA
07:30
- 08:30
Morning Session 3 – Meet the Experts: CAR T and other Cell “Vehicles”

Sarah Nikiforow, MD, PhD (Chair)
Dana-Farber Cancer Institute, USA
07:30
- 08:30
Q&O Track 4: Current Clinical Development Regulatory Guidance – Context and Implications

Kurt Gunter, MD (Chair)
Cell Medica Inc., USA

Peiman Hematti, MD
University of Wisconsin-Madison School of Medicine and Public Health, USA

Cynthia Molina
Triumvira, USA
08:45
- 10:15
Plenary 3: Redirecting Immune Cells – T and NK cells aside from canonical CARs

Sarah Nikiforow, MD, PhD (Chair)
Dana-Farber Cancer Institute, USA

Denis-Claude Roy, MD, FRCPC
Hopital Maisonneuve-Rosemont, Canada

Lisa Butterfield, PhD
University of Pittsburgh Department of Medicine, USA

Sumithira Vasu, MBBS
Comprehensive Cancer Center, Ohio State University, USA
10:45
- 12:15
Oral Abstracts Session 2

Jacques Galipeau, MD (Chair)
University of Wisconsin - Madison, USA
10:45
- 12:15
Advanced Practice Professionals* (APP) Track Session 1: Management of CRS toxicity or other reactions related to CAR therapy
Valkal Bhatt, PharmD, BCOP, BCPS (Chair)
Memorial Sloan Kettering Cancer Center, USA

Christina Bachmeier, PharmD, BCOP
Moffitt Cancer Center, USA

Rebecca Gonzalez, PharmD, BCOP
Moffitt Cancer Center, USA